ホーム › 非小細胞肺癌 › ニュージャージー › Edison
Edison、NJにおける非小細胞肺癌の臨床試験
Edisonとその周辺地域（約30マイル以内）の拠点で、非小細胞肺癌に関する47件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
被験者募集中第2相
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15マイル先
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
被験者募集中第1相
- START New Jersey, East Brunswick · 6マイル先
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
被験者募集中第1相
- Exelixis Clinical Site #88, East Brunswick · 6マイル先
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
被験者募集中第2/3相
- Astera Cancer Care /ID# 277570, East Brunswick · 6マイル先
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
被験者募集中第2相
- START New Jersey, East Brunswick · 6マイル先
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
被験者募集中第1相
- Research Site, New Brunswick · 3マイル先
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
被験者募集中第1/2相
- Astera Cancer Care /ID# 271915, East Brunswick · 6マイル先
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
被験者募集中第2相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
被験者募集中第2相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
被験者募集中第2相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
被験者募集中第2/3相
- Astera Cancer Care, East Brunswick · 6マイル先
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
被験者募集中第2相
- Astera Cancer Care /ID# 272359, East Brunswick · 6マイル先
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
被験者募集中第1/2相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
被験者募集中第3相
- Clinical Study Site, New Brunswick · 3マイル先
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
被験者募集中第3相
- Astera Cancer Care, Edison
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
被験者募集中第1相
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15マイル先
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
被験者募集中第2/3相
- Local Institution - 007-975-A, Somerset · 4マイル先
- Local Institution - 007-975-B, Somerset · 4マイル先
- Local Institution - 007-975-C, Somerset · 4マイル先
- 他2件
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
被験者募集中第2相
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
Using Urine Samples to Identify Lung Cancer
被験者募集中観察研究健康なボランティア歓迎
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15マイル先
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
被験者募集中第1/2相
- START New Jersey East Brunswick, East Brunswick · 6マイル先
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
被験者募集中観察研究
- Astera Cancer Care, East Brunswick · 6マイル先
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
被験者募集中第2相
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
被験者募集中第1相
- Site 104 - START New Jersey, East Brunswick · 6マイル先
A Phase 1/1b Study of IAM1363 in HER2 Cancers
被験者募集中第1相
- Rutgers Cancer Institute, New Brunswick · 3マイル先
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
被験者募集中
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
被験者募集中第1相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
被験者募集中第1相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
被験者募集中第2相
- Astera Cancer Care, East Brunswick · 6マイル先
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
被験者募集中第3相
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15マイル先
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
被験者募集中第2相
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15マイル先
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
被験者募集中第1/2相
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15マイル先
Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer
被験者募集中観察研究
- Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge · 15マイル先
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
被験者募集中第1相
- START Astera, LLC, East Brunswick · 6マイル先
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
被験者募集中第1相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
被験者募集中第2相
- Virtua Voorhees, Voorhees Township · 5マイル先
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
被験者募集中第1/2相
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15マイル先
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
被験者募集中第2相
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15マイル先
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2相
- Virtua Voorhees, Voorhees Township · 5マイル先
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2相
- Virtua Voorhees, Voorhees Township · 5マイル先
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15マイル先
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
被験者募集中第2相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2/3相
- Virtua Voorhees, Voorhees Township · 5マイル先
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
被験者募集中第1/2相
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15マイル先
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer
被験者募集中第2相
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15マイル先
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
被験者募集中第2相
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15マイル先
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
被験者募集中第2相
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
被験者募集中第1/2相
- START, Astera, East Brunswick · 6マイル先
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, New Brunswick · 3マイル先
他の都市における非小細胞肺癌の試験
- Houston, TX145件の研究
- New York City, NY120件の研究
- Arlington, VA104件の研究
- Nashville, TN97件の研究
- Boston, MA90件の研究
- Los Angeles, CA87件の研究
- St. Louis, MO73件の研究
- Chicago, IL61件の研究
- Baltimore, MD60件の研究
- San Antonio, TX59件の研究
- Columbus, OH56件の研究
- Washington, DC55件の研究
Edisonにおける他の研究
- 乳がん68件の研究
- がん（全種類）33件の研究
- 前立腺がん29件の研究
- 大腸癌23件の研究
- 肺がん23件の研究
- 多発性骨髄腫22件の研究
- 膀胱癌21件の研究
- 転移性癌20件の研究
- 卵巣がん20件の研究
- 急性骨髄性白血病20件の研究
- 子宮内膜がん19件の研究
- 尿路上皮（移行上皮）癌18件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。